Mortality by Vascular Access Type
Live query onptdata — state = 'Dead', grouped by access.
Generated: 2026-09-21 23:14
Total deaths
289
Catheter-related deaths
60.6 %
175 patients
AVF deaths
25.6 %
74 patients
Highest-rate access
PERM
54.5% crude death rate
Deaths by access type (counts)
Share of deaths
Crude death rate per access type (deaths ÷ all patients ever on that access)
Crude rate is not risk-adjusted (age, diabetes and vintage differ between access groups) — but it is the fastest signal for whether catheters are over-represented among your deaths.
Automatic analysis
Total deaths analysed: 289.
Suggested action: Use this page together with the whole-cohort access distribution to interpret ratios.
60.6% of deaths (175 patients) occurred in patients on catheters (PERM + SUB).
Suggested action: Catheter reduction is your highest-yield mortality intervention. Launch a Fistula-First programme: early vein mapping, timely surgical referral, and a catheter-removal target of <10% prevalent use.
Crude death rate is 54.5% on PERM vs 46.3% on AVF (+8.2 percentage points).
Suggested action: Consistent with international data — catheters drive mortality. Use this to justify resource requests for access surgery and interventional radiology.
Highest crude death rate is on PERM (54.5%).
Suggested action: Audit the PERM subgroup: was the catheter unavoidable (emergency start, poor veins) or avoidable (late referral, delayed surgery)?
What this parameter means
The type of vascular access a patient was using when they died. Access type is one of the strongest modifiable predictors of survival in dialysis. Central venous catheters are associated with 2–3× the mortality of arteriovenous fistulas, mostly through bloodstream infection, thrombosis and inadequate dialysis dose.
Access types explained
- AVF — native arteriovenous fistula. First choice, lowest infection, best survival.
- AVG — prosthetic graft. Higher infection and thrombosis than AVF.
- PERM — tunnelled central catheter. Long-term use is a red flag.
- SUB — subclavian / temporary central catheter. Emergency or bridging; ideal is < 10% of prevalent use.
Why catheter patients die more
- Catheter-related bloodstream infection (CRBSI)
- Central venous stenosis and thrombosis
- Chronic inflammation (high CRP) and ESA resistance
- Under-dialysis from low achievable blood flow
- Bacterial endocarditis and metastatic infection
- Often a marker of late referral, frailty or comorbidity
Why a unit ends up catheter-heavy
- Late nephrology referral — crash-landing on dialysis
- Long wait for access surgery or interventional radiology
- Fistula failure without a repeat-creation programme
- Insufficient pre-dialysis vein mapping and vessel preservation
- Cannulation skill gaps that push staff to keep catheters
- Elderly / frail patients not referred for AVF creation
Action plan — catheter reduction, review every 6 months
- Target prevalent catheter use < 10%. Report it monthly on this page as the counterpart to the death distribution.
- Early referral. Every patient with eGFR < 20 should have a vascular mapping and surgical referral — before dialysis starts.
- Fistula-First protocol. Document the reason for every catheter insertion (emergency start, no suitable veins, patient refusal). Audit the "avoidable" category.
- Cannulation training. Skilled buttonhole or rope-ladder cannulation reduces early AVF failure and delays conversion back to catheters.
- Access surveillance programme. Flow monitoring every 3 months; pre-emptive angioplasty for stenosis > 50%.
- CRBSI bundle. Hand hygiene, hub disinfection, sterile dressing, antimicrobial locks; target < 1 CRBSI per 1000 catheter-days.
- Interventional capacity. Track wait time from referral to access creation and from dysfunction to intervention — these are the two bottlenecks that keep catheters alive.
- Crude death rates are not risk-adjusted. Complement this page with an age- and diabetes-stratified analysis (next parameter) to be sure catheter use itself is driving mortality in your population, not just serving as a marker for it.
Data table
| Access type | Deaths | % of deaths | Patients ever on access | Crude death rate | Share of deaths |
|---|---|---|---|---|---|
| PERM | 158 | 54.7% | 290 | 54.5% | |
| AVF | 74 | 25.6% | 160 | 46.3% | |
| SUB | 17 | 5.9% | 36 | 47.2% | |
| AVG | 40 | 13.8% | 79 | 50.6% | |
| Total | 289 | 100% | 565 | — |